← All trials
NCT05029401
Phase 1/Phase 2Interventional
Trials that are a combination of phases 1 and 2.
View on ClinicalTrials.gov ↗Timeline
- Start date
- Apr 1, 2021
- Primary completion
- Aug 31, 2023
- Completion date
- Oct 31, 2023
- First posted
- Aug 31, 2021
- Last posted
- Sep 5, 2021
- Enrollment
- 110
- Arms / groups
- 2 / —
- Source
- AACT · ingestion pipeline
Sponsors
- DemeRx IB, Inc.Lead sponsor
- ERT ClinicalCollaborator
- MAC Clinical ResearchCollaborator
Drugs studied
Indications studied
CDEK-curated fields only — the ClinicalTrials.gov results mirror (baseline measures, adverse events, participant flow) is a separate, currently-dormant pipeline; see MIGRATION_PLAN.md.